NIVANEX DMX- guaifenesin, dextromethorphan hydrobromide, and phenylephrine hydrochloride tablet
Nivagen Pharmaceuticals, Inc.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
Temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:
Do not exceed recommended dosage.
Do not exceed recommended dosage.
Adults and children 12 years of age and over | 1 tablet every 4 hours, not to exceed 6 tablets in 24 hours. |
Children 6 to under 12 years of age | 1/2 tablet every 4 hours, not to exceed 3 tablets in 24 hours. |
Children under 6 years of age | Consult a physician. |
D&C Yellow # 10, FD&C Yellow # 6, Magnesium Stearate, Microcrystalline Cellulose, Sodium Starch Glycolate.
Distributed by: Nivagen Pharmaceuticals, Inc
Sacramento, CA 95827 USA
Customer Service Number: 1-877-977-0687
NDC 75834-040-60
NIVAGEN
PHARMACEUTICALS
Nivanex DMX™
COUGH SUPPRESSANT • EXPECTORANT
NASAL DECONGESTANT
EACH TABLET CONTAINS:
Dextromethorphan HBr
15 mg
Guaifenesin
380 mg
Phenylephrine HCl
10 mg
Tamper evident by foil seal under cap.
Do not use if foil seal is broken or missing
60 TABLETS
NIVANEX DMX
guaifenesin, dextromethorphan hydrobromide, and phenylephrine hydrochloride tablet |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Labeler - Nivagen Pharmaceuticals, Inc. (052032418) |